{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:37:13Z","timestamp":1776339433771,"version":"3.51.2"},"reference-count":339,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["572\/12"],"award-info":[{"award-number":["572\/12"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.pharmthera.2020.107551","type":"journal-article","created":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T23:15:07Z","timestamp":1587165307000},"page":"107551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Cannabinoids as therapeutics for PTSD"],"prefix":"10.1016","volume":"211","author":[{"given":"Brenda","family":"Sbarski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irit","family":"Akirav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb0005","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/hipo.20711","article-title":"Cannabinoids modulate hippocampal memory and plasticity","volume":"20","author":"Abush","year":"2010","journal-title":"Hippocampus"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb0010","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/npp.2013.51","article-title":"Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory","volume":"38","author":"Abush","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0015","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/S1461145709990496","article-title":"CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD","volume":"13","author":"Adamec","year":"2010","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb0020","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1176\/appi.ajp.161.8.1488","article-title":"Low-dose cortisol for symptoms of posttraumatic stress disorder","volume":"161","author":"Aerni","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0025","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.euroneuro.2017.06.006","article-title":"The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event","volume":"27","author":"Aisenberg","year":"2017","journal-title":"European Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0030","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18ac12473","article-title":"Are there effective psychopharmacologic treatments for PTSD?","volume":"80","author":"Akiki","year":"2018","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb0035","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.neubiorev.2013.08.002","article-title":"Cannabinoids and glucocorticoids modulate emotional memory after stress","volume":"37","author":"Akirav","year":"2013","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0045","article-title":"Pharmacological interventions for preventing post-traumatic stress disorder (PTSD)","volume":"7","author":"Amos","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2020.107551_bb0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1155\/2011\/928497","article-title":"Corticotrophin-releasing hormone type 1 receptor gene (CRHR1) variants predict posttraumatic stress disorder onset and course in pediatric injury patients","volume":"30","author":"Amstadter","year":"2011","journal-title":"Disease Markers"},{"issue":"23","key":"10.1016\/j.pharmthera.2020.107551_bb0055","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.3390\/ijms20235875","article-title":"The endocannabinoid system in pediatric inflammatory and immune diseases","volume":"20","author":"Argenziano","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0060","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/appi.ajp.162.5.992","article-title":"Higher levels of basal serial CSF cortisol in combat veterans with posttraumatic stress disorder","volume":"162","author":"Baker","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yfrne.2017.07.005","article-title":"Endocannabinoids: Effectors of glucocorticoid signaling","volume":"47","author":"Balsevich","year":"2017","journal-title":"Frontiers in Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.nbd.2009.11.020","article-title":"Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission","volume":"37","author":"Bambico","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107551_bb0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jnr.23812","article-title":"Sex-specific mechanisms for responding to stress","volume":"95","author":"Bangasser","year":"2017","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.physbeh.2017.09.025","article-title":"Sex differences in stress regulation of arousal and cognition","volume":"187","author":"Bangasser","year":"2018","journal-title":"Physiology and Behavior"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0085","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.euroneuro.2014.07.005","article-title":"Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress","volume":"24","author":"Bedse","year":"2014","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0090","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.phrs.2016.07.024","article-title":"The endocannabinoid system and post-traumatic stress disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings","volume":"111","author":"Berardi","year":"2016","journal-title":"Pharmacological Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Current Drug Safety"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pnpbp.2008.12.004","article-title":"Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review","volume":"33","author":"Berger","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11920-015-0564-2","article-title":"Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): What have we learned?","volume":"17","author":"Bernardy","year":"2015","journal-title":"Current Psychiatry Reports"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0110","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.psyneuen.2009.05.021","article-title":"The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders","volume":"34","author":"Binder","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb0115","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1001\/jama.299.11.1291","article-title":"Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults","volume":"299","author":"Binder","year":"2008","journal-title":"Jama"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0120","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fnins.2018.00502","article-title":"Cannabidiol as a therapeutic alternative for post-traumatic stress disorder: From bench research to confirmation in human trials","volume":"12","author":"Bitencourt","year":"2018","journal-title":"Frontiers in Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0125","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuropharm.2012.05.039","article-title":"A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers","volume":"64","author":"Bitencourt","year":"2013","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jamapsychiatry.2015.3229","article-title":"Cannabis use and risk of psychiatric disorders: Prospective evidence from a US national longitudinal study","volume":"73","author":"Blanco","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.53","article-title":"Central anandamide deficiency predicts stress-induced anxiety: Behavioral reversal through endocannabinoid augmentation","volume":"4","author":"Bluett","year":"2014","journal-title":"Translational Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1521\/jscp.2013.32.3.296","article-title":"Emotion regulation and posttraumatic stress disorder: A prospective investigation","volume":"32","author":"Boden","year":"2013","journal-title":"Journal of Social and Clinical Psychology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0150","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jts.20243","article-title":"Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users","volume":"20","author":"Bonn-Miller","year":"2007","journal-title":"Journal of Traumatic Stress"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/16506073.2010.525253","article-title":"Posttraumatic stress, difficulties in emotion regulation, and coping-oriented marijuana use","volume":"40","author":"Bonn-Miller","year":"2011","journal-title":"Cognitive Behaviour Therapy"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drugalcdep.2013.12.008","article-title":"Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD","volume":"136","author":"Bonn-Miller","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0165","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5498\/wjp.v5.i4.387","article-title":"Animal models for posttraumatic stress disorder: An overview of what is used in research","volume":"5","author":"Borghans","year":"2015","journal-title":"World Journal of Psychiatry"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb0170","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.biopsych.2006.12.001","article-title":"Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress","volume":"62","author":"Bortolato","year":"2007","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1037\/0022-006X.64.1.191","article-title":"Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: Findings and clinical implications","volume":"64","author":"Boscarino","year":"1996","journal-title":"Journal of Consulting and Clinical Psychology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/174728","article-title":"Conceptualizing and treating comorbid chronic pain and PTSD","volume":"2013","author":"Bosco","year":"2013","journal-title":"Pain Research and Treatment"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yhbeh.2011.03.011","article-title":"Behavioral effects of chronic adolescent stress are sustained and sexually dimorphic","volume":"60","author":"Bourke","year":"2011","journal-title":"Hormones and Behavior"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0190","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.yhbeh.2012.02.024","article-title":"Stress-induced sex differences: Adaptations mediated by the glucocorticoid receptor","volume":"62","author":"Bourke","year":"2012","journal-title":"Hormones and Behavior"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0195","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.psyneuen.2012.05.001","article-title":"Glucocorticoid sensitizers Bag1 and Ppid are regulated by adolescent stress in a sex-dependent manner","volume":"38","author":"Bourke","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1037\/0033-295X.108.1.4","article-title":"A modern learning theory perspective on the etiology of panic disorder","volume":"108","author":"Bouton","year":"2001","journal-title":"Psychological Review"},{"key":"10.1016\/j.pharmthera.2020.107551_bb5020","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/npp.2014.225","article-title":"Interaction between the cholecystokinin and endogenous cannabinoid systems in cued fear expression and extinction retention","volume":"40","author":"Bowers","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbr.2015.12.005","article-title":"Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice","volume":"300","author":"Bowers","year":"2016","journal-title":"Behavioural Brain Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/09540260902782760","article-title":"Basic neuroanatomy and neuropharmacology of cannabinoids","volume":"21","author":"Breivogel","year":"2009","journal-title":"International Review of Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0215","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1176\/ajp.154.5.624","article-title":"Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder","volume":"154","author":"Bremner","year":"1997","journal-title":"The American Journal of Psychiatry"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb0220","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archpsyc.1997.01830230082012","article-title":"Sex differences in posttraumatic stress disorder","volume":"54","author":"Breslau","year":"1997","journal-title":"Archives of General Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb0225","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archpsyc.55.7.626","article-title":"Trauma and posttraumatic stress disorder in the community: The 1996 Detroit area survey of trauma","volume":"55","author":"Breslau","year":"1998","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0235","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40779-015-0053-2","article-title":"Primary prevention of posttraumatic stress disorder: Drugs and implications","volume":"2","author":"Burbiel","year":"2015","journal-title":"Military Medical Research"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pnpbp.2018.01.026","article-title":"Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD","volume":"84","author":"Burstein","year":"2018","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0245","series-title":"Cannabinoids","first-page":"385","article-title":"Effects on the immune system","volume":"168","author":"Cabral","year":"2005"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0250","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/JCP.0000000000000180","article-title":"Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder\u2013related insomnia and nightmares, chronic pain, harm reduction, and other indications: A retrospective evaluation","volume":"34","author":"Cameron","year":"2014","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1607","key":"10.1016\/j.pharmthera.2020.107551_bb0255","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philosophical Transactions of the Royal Society, B: Biological Sciences"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neubiorev.2016.02.005","article-title":"Genetics of glucocorticoid regulation and posttraumatic stress disorder\u2014What do we know?","volume":"63","author":"Castro-Vale","year":"2016","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0265","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/sj.npp.1300655","article-title":"Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear","volume":"30","author":"Chhatwal","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/07853890310017044","article-title":"Corticotropin-releasing hormone (CRH) in psychiatry: From stress to psychopathology","volume":"36","author":"Claes","year":"2004","journal-title":"Annals of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1196\/annals.1314.014","article-title":"An animal model of posttraumatic stress disorder: The use of cut-off behavioral criteria","volume":"1032","author":"Cohen","year":"2004","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0280","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.biopsych.2005.12.003","article-title":"Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats","volume":"59","author":"Cohen","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb0285","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.biopsych.2008.05.025","article-title":"Early post-stressor intervention with high-dose corticosterone attenuates posttraumatic stress response in an animal model of posttraumatic stress disorder","volume":"64","author":"Cohen","year":"2008","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ilar\/ilu006","article-title":"Maintaining the clinical relevance of animal models in translational studies of post-traumatic stress disorder","volume":"55","author":"Cohen","year":"2014","journal-title":"ILAR Journal"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0295","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2016.03.010","article-title":"Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence","volume":"64","author":"Colizzi","year":"2016","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0300","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1037\/a0023076","article-title":"Posttraumatic stress disorder and cannabis use in a nationally representative sample","volume":"25","author":"Cougle","year":"2011","journal-title":"Psychology of Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1101\/lm.043000.116","article-title":"Dynamic expression of FKBP5 in the medial prefrontal cortex regulates resiliency to conditioned fear","volume":"24","author":"Criado-Marrero","year":"2017","journal-title":"Learning & Memory"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0310","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): Toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cpr.2015.10.003","article-title":"Psychological treatments for adults with posttraumatic stress disorder: A systematic review and meta-analysis","volume":"43","author":"Cusack","year":"2016","journal-title":"Clinical Psychology Review"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0320","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.psyneuen.2017.09.023","article-title":"Blunted basal corticosterone pulsatility predicts post-exposure susceptibility to PTSD phenotype in rats","volume":"87","author":"Danan","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biopsych.2013.04.019","article-title":"Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion","volume":"74","author":"D\u2019Andrea","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0330","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-012-2955-y","article-title":"Cannabidiol enhances consolidation of explicit fear extinction in humans","volume":"226","author":"Das","year":"2013","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0335","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ecl.2013.05.004","article-title":"Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment","volume":"42","author":"Daskalakis","year":"2013","journal-title":"Endocrinology and Metabolism Clinics"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0340","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1037\/a0031525","article-title":"Treatment adherence in cognitive processing therapy for combat-related PTSD with history of mild TBI","volume":"58","author":"Davis","year":"2013","journal-title":"Rehabilitation Psychology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0345","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: From adaptation to disease","volume":"6","author":"De Kloet","year":"2005","journal-title":"Nature Reviews Neuroscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0350","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jpsychires.2005.08.002","article-title":"Assessment of HPA-axis function in posttraumatic stress disorder: Pharmacological and non-pharmacological challenge tests, a review","volume":"40","author":"De Kloet","year":"2006","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0355","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.psyneuen.2006.12.009","article-title":"Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder","volume":"32","author":"De Kloet","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0360","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/nrn.2016.155","article-title":"Stress, glucocorticoids and memory: Implications for treating fear-related disorders","volume":"18","author":"De Quervain","year":"2017","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0365","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00213-018-5116-0","article-title":"Glucocorticoid-induced enhancement of extinction\u2014From animal models to clinical trials","volume":"236","author":"De Quervain","year":"2019","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0370","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0006-3223(00)00896-9","article-title":"Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims","volume":"48","author":"Delahanty","year":"2000","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0375","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S1092852913000096","article-title":"The efficacy of initial hydrocortisone administration at preventing posttraumatic distress in adult trauma patients: A randomized trial","volume":"18","author":"Delahanty","year":"2013","journal-title":"CNS Spectrums"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb0380","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.biopsych.2017.11.019","article-title":"Current status of animal models of posttraumatic stress disorder: Behavioral and biological phenotypes, and future challenges in improving translation","volume":"83","author":"Deslauriers","year":"2018","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0385","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107551_bb8000","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2013.04.045","article-title":"Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors","volume":"250","author":"Do Monte","year":"2013","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0390","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1038\/s41467-019-09926-z","article-title":"Individual variability in behavior and functional networks predicts vulnerability using an animal model of PTSD","volume":"10","author":"Dopfel","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0395","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pnpbp.2018.10.010","article-title":"The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions","volume":"89","author":"Dunlop","year":"2019","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0400","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biopsych.2017.06.024","article-title":"Corticotropin-releasing factor receptor 1 antagonism is ineffective for women with posttraumatic stress disorder","volume":"82","author":"Dunlop","year":"2017","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.2014.920118","article-title":"Marijuana, expectancies, and post-traumatic stress symptoms: A preliminary investigation","volume":"46","author":"Earleywine","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb0410","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.biopsych.2013.05.039","article-title":"Overexpression of corticotropin-releasing factor receptor type 2 in the bed nucleus of stria terminalis improves posttraumatic stress disorder-like symptoms in a model of incubation of fear","volume":"74","author":"Elharrar","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0415","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1089\/acm.2018.0437","article-title":"Cannabidiol in the treatment of post-traumatic stress disorder: A case series","volume":"25","author":"Elms","year":"2019","journal-title":"The Journal of Alternative and Complementary Medicine"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psychres.2019.01.097","article-title":"Posttraumatic stress disorder and traumatic brain injury: Sex differences in veterans","volume":"274","author":"Epstein","year":"2019","journal-title":"Psychiatry Research"},{"issue":"76","key":"10.1016\/j.pharmthera.2020.107551_bb0425","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/1463-1741.155838","article-title":"Noise stress changes mRNA expressions of corticotropin-releasing hormone, its receptors in amygdala, and anxiety-related behaviors","volume":"17","author":"Eraslan","year":"2015","journal-title":"Noise & Health"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0430","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/03602532.2018.1428343","article-title":"Pro-psychotic effects of synthetic cannabinoids: Interactions with central dopamine, serotonin, and glutamate systems","volume":"50","author":"Fantegrossi","year":"2018","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0435","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.psyneuen.2009.08.008","article-title":"Sex differences in the self-administration of cannabinoids and other drugs of abuse","volume":"34","author":"Fattore","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0440","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.euroneuro.2018.02.004","article-title":"Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD","volume":"28","author":"Fidelman","year":"2018","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0445","series-title":"Behavioral neurobiology of PTSD","first-page":"47","article-title":"Animal models of PTSD: A critical review","volume":"38","author":"Flandreau","year":"2017"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0450","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psyneuen.2011.04.014","article-title":"Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus","volume":"37","author":"Flandreau","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-clinpsy-021815-093533","article-title":"The efficacy of exposure therapy for anxiety-related disorders and its underlying mechanisms: The case of OCD and PTSD","volume":"12","author":"Foa","year":"2016","journal-title":"Annual Review of Clinical Psychology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0460","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1755-5949.2008.00071.x","article-title":"The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)","volume":"15","author":"Fraser","year":"2009","journal-title":"CNS Neuroscience and Therapeutics"},{"issue":"36","key":"10.1016\/j.pharmthera.2020.107551_bb0465","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1523\/JNEUROSCI.1223-09.2009","article-title":"Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance","volume":"29","author":"Ganon-Elazar","year":"2009","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0470","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/npp.2011.204","article-title":"Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress","volume":"37","author":"Ganon-Elazar","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0475","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.psyneuen.2013.01.014","article-title":"Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit","volume":"38","author":"Ganon-Elazar","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0480","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/da.10103","article-title":"The weaker sex? Gender and post-traumatic stress disorder","volume":"17","author":"Gavranidou","year":"2003","journal-title":"Depression and Anxiety"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb6000","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu026","article-title":"PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation","volume":"18","author":"Gazarini","year":"2015","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0485","doi-asserted-by":"crossref","first-page":"493","DOI":"10.29252\/nirp.bcn.8.6.493","article-title":"Effect of WIN55-212-2 and consequences of extinction training on conditioned fear memory in PTSD male rats","volume":"8","author":"Ghasemi","year":"2017","journal-title":"Basic and Clinical Neuroscience"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb0490","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nn958","article-title":"Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma","volume":"5","author":"Gilbertson","year":"2002","journal-title":"Nature Neuroscience"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/jts.20372","article-title":"Low cortisol, high DHEA, and high levels of stimulated TNF-\u03b1, and IL-6 in women with PTSD","volume":"21","author":"Gill","year":"2008","journal-title":"Journal of Traumatic Stress"},{"issue":"51","key":"10.1016\/j.pharmthera.2020.107551_bb0500","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0505","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1523\/JNEUROSCI.3021-09.2010","article-title":"Sex differences in stress response circuitry activation dependent on female hormonal cycle","volume":"30","author":"Goldstein","year":"2010","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0510","doi-asserted-by":"crossref","first-page":"393251","DOI":"10.1155\/2012\/393251","article-title":"A pilot study of mifepristone in combat-related PTSD","volume":"2012","author":"Golier","year":"2012","journal-title":"Depression Research and Treatment"},{"key":"10.1016\/j.pharmthera.2020.107551_bb7000","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0269881110389095","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors","volume":"26","author":"Gomes","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0515","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fnins.2013.00089","article-title":"Animal models of post-traumatic stress disorder: Face validity","volume":"7","author":"Goswami","year":"2013","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0520","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brat.2014.07.012","article-title":"Bridging the gap: Lessons we have learnt from the merging of psychology and psychiatry for the optimisation of treatments for emotional disorders","volume":"62","author":"Graham","year":"2014","journal-title":"Behaviour Research and Therapy"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0525","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","article-title":"Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety","volume":"35","author":"Gray","year":"2015","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0530","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psyneuen.2016.01.004","article-title":"Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function","volume":"66","author":"Gray","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","article-title":"PTSD symptom reports of patients evaluated for the New Mexico medical Cannabis program","volume":"46","author":"Greer","year":"2014","journal-title":"Journal of Psychoactive Drugs"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0540","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nature Reviews Drug Discovery"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb0545","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.tips.2013.08.008","article-title":"Amygdala FAAH and anandamide: Mediating protection and recovery from stress","volume":"34","author":"Gunduz-Cinar","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0550","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neuropharm.2011.02.016","article-title":"Modulation of the serotonin system by endocannabinoid signaling","volume":"61","author":"Haj-Dahmane","year":"2011","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0555","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2522\/ptj.20130597","article-title":"Chronic stress, cortisol dysfunction, and pain: A psychoneuroendocrine rationale for stress management in pain rehabilitation","volume":"94","author":"Hannibal","year":"2014","journal-title":"Physical Therapy"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0560","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jad.2018.09.058","article-title":"GxE effects of FKBP5 and traumatic life events on PTSD: A meta-analysis","volume":"243","author":"Hawn","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0565","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0006-3223(01)01157-X","article-title":"The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies","volume":"49","author":"Heim","year":"2001","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0570","first-page":"13","article-title":"Neurobiology of posttraumatic stress disorder","volume":"14","author":"Heim","year":"2009","journal-title":"CNS Spectrums"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4530(99)00035-9","article-title":"The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders","volume":"25","author":"Heim","year":"2000","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0580","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/B:JOTS.0000004078.93012.7d","article-title":"Do patients drop out prematurely from exposure therapy for PTSD?","volume":"16","author":"Hembree","year":"2003","journal-title":"Journal of Traumatic Stress"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0585","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0590","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fnbeh.2013.00061","article-title":"Neural control of chronic stress adaptation","volume":"7","author":"Herman","year":"2013","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0595","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fendo.2016.00137","article-title":"Paraventricular hypothalamic mechanisms of chronic stress adaptation","volume":"7","author":"Herman","year":"2016","journal-title":"Frontiers in Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0600","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0306-4522(01)00509-7","article-title":"Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain","volume":"109","author":"Hermann","year":"2002","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107551_bb0605","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.molbrainres.2004.08.005","article-title":"The effects of acute stress on the regulation of central and basolateral amygdala CRF-binding protein gene expression","volume":"131","author":"Herringa","year":"2004","journal-title":"Molecular Brain Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb0610","first-page":"5","article-title":"Posttraumatic stress disorder: Epidemiology and health-related considerations","volume":"61","author":"Hidalgo","year":"2000","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0615","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.pnpbp.2009.11.001","article-title":"Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids","volume":"34","author":"Hill","year":"2010","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0620","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuroscience.2011.12.030","article-title":"Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis","volume":"204","author":"Hill","year":"2012","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0625","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.psyneuen.2007.02.003","article-title":"Estrogen recruits the endocannabinoid system to modulate emotionality","volume":"32","author":"Hill","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"13","key":"10.1016\/j.pharmthera.2020.107551_bb0630","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/npp.2009.114","article-title":"Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic\u2013pituitary\u2013adrenal axis","volume":"34","author":"Hill","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0635","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1016\/j.psyneuen.2013.08.004","article-title":"Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade Center attacks","volume":"38","author":"Hill","year":"2013","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0640","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2017.162","article-title":"Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder","volume":"43","author":"Hill","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0645","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.smim.2014.04.001","article-title":"Stress regulates endocannabinoid-CB1 receptor signaling","volume":"26","author":"Hillard","year":"2014","journal-title":"Seminars in Immunology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0650","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2017.tb00740.x","article-title":"Endocannabinoid Signaling and the hypothalamic-pituitary-adrenal Axis","volume":"7","author":"Hillard","year":"2011","journal-title":"Comprehensive Physiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0655","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cpr.2007.04.009","article-title":"Cognitive processes during fear acquisition and extinction in animals and humans: Implications for exposure therapy of anxiety disorders","volume":"28","author":"Hofmann","year":"2008","journal-title":"Clinical Psychology Review"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2020.107551_bb0660","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ejphar.2007.12.032","article-title":"Central CRH system in depression and anxiety\u2014Evidence from clinical studies with CRH1 receptor antagonists","volume":"583","author":"Holsboer","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0665","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.psyneuen.2013.10.003","article-title":"Linking plasma cortisol levels to phenotypic heterogeneity of posttraumatic stress symptomatology","volume":"39","author":"Horn","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0670","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1192\/bjp.bp.114.148551","article-title":"Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis","volume":"206","author":"Hoskins","year":"2015","journal-title":"The British Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0675","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","article-title":"The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans","volume":"90","author":"Hysek","year":"2011","journal-title":"Clinical Pharmacology & Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0680","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1017\/S1461145711001209","article-title":"Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD)","volume":"15","author":"Ipser","year":"2012","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb0685","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: New therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends in Pharmacological Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0690","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.janxdis.2013.04.010","article-title":"Evaluating treatment of posttraumatic stress disorder with cognitive processing therapy and prolonged exposure therapy in a VHA specialty clinic","volume":"28","author":"Jeffreys","year":"2014","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0695","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.psyneuen.2014.11.002","article-title":"The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study","volume":"51","author":"Jetly","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0700","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2014.09.020","article-title":"Corticosterone mitigates the stress response in an animal model of PTSD","volume":"60","author":"Jia","year":"2015","journal-title":"Journal of Psychiatric Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0705","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrn2632","article-title":"The neuro-symphony of stress","volume":"10","author":"Jo\u00ebls","year":"2009","journal-title":"Nature Reviews Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0710","series-title":"Monitoring the future national survey results on drug use, 1975\u20132015: Volume II, College students and adults ages 19\u201355","author":"Johnston","year":"2016"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0715","first-page":"e13356","article-title":"Psychophysiological treatment outcomes: Corticotropin-releasing factor type 1 receptor antagonist increases inhibition of fear-potentiated startle in PTSD patients","author":"Jovanovic","year":"2019","journal-title":"Psychophysiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0720","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1152\/physrev.00019.2008","article-title":"Endocannabinoid-mediated control of synaptic transmission","volume":"89","author":"Kano","year":"2009","journal-title":"Physiological Reviews"},{"issue":"25","key":"10.1016\/j.pharmthera.2020.107551_bb0725","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.2174\/13816128113199990620","article-title":"Acute and long-term effects of cannabis use: A review","volume":"20","author":"Karila","year":"2014","journal-title":"Current Pharmaceutical Design"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0730","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0196-9781(01)00399-0","article-title":"Corticotropin-releasing hormone in depression and post-traumatic stress disorder","volume":"22","author":"Kasckow","year":"2001","journal-title":"Peptides"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb0735","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"Journal of Neuroscience"},{"issue":"23","key":"10.1016\/j.pharmthera.2020.107551_bb0740","doi-asserted-by":"crossref","first-page":"9506","DOI":"10.1523\/JNEUROSCI.21-23-09506.2001","article-title":"Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission","volume":"21","author":"Katona","year":"2001","journal-title":"Journal of Neuroscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb0745","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/da.21997","article-title":"Early interventions for PTSD: A review","volume":"29","author":"Kearns","year":"2012","journal-title":"Depression and Anxiety"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0750","doi-asserted-by":"crossref","first-page":"31858","DOI":"10.3402\/ejpt.v7.31858","article-title":"PTSD: From neurobiology to pharmacological treatments","volume":"7","author":"Kelmendi","year":"2016","journal-title":"European Journal of Psychotraumatology"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0755","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the National Comorbidity Survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0760","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1037\/adb0000110","article-title":"Associations among trauma, posttraumatic stress disorder, cannabis use, and cannabis use disorder in a nationally representative epidemiologic sample","volume":"29","author":"Kevorkian","year":"2015","journal-title":"Psychology of Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0765","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: A reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harvard Review of Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0770","first-page":"47","article-title":"The self-medication hypothesis revisited: The dually diagnosed patient","volume":"10","author":"Khantzian","year":"2003","journal-title":"Primary Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0775","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11481-005-9007-x","article-title":"Cannabinoid-induced immune suppression and modulation of antigen-presenting cells","volume":"1","author":"Klein","year":"2006","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0780","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nn.3275","article-title":"Allele-specific FKBP5 DNA demethylation mediates gene\u2013childhood trauma interactions","volume":"16","author":"Klengel","year":"2013","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0785","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neuroscience.2007.05.041","article-title":"Glucocorticoid receptor activation is involved in producing abnormal phenotypes of single-prolonged stress rats: A putative post-traumatic stress disorder model","volume":"148","author":"Kohda","year":"2007","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0790","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1038\/npp.2014.132","article-title":"Cannabinoids prevent the effects of a footshock followed by situational reminders on emotional processing","volume":"39","author":"Korem","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0795","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/jbcpp-2015-0058","article-title":"Targeting the endocannabinoid system to treat anxiety-related disorders","volume":"27","author":"Korem","year":"2016","journal-title":"Journal of Basic and Clinical Physiology and Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0800","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuroscience.2017.06.015","article-title":"Role of beta-catenin and endocannabinoids in the nucleus accumbens in extinction in rats exposed to shock and reminders","volume":"357","author":"Korem","year":"2017","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb0805","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biopsych.2017.03.007","article-title":"It is time to address the crisis in the pharmacotherapy of posttraumatic stress disorder: A consensus statement of the PTSD psychopharmacology working group","volume":"82","author":"Krystal","year":"2017","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0810","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/tp.2014.3","article-title":"Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder","volume":"4","author":"Labonte","year":"2014","journal-title":"Translational Psychiatry"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0815","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/da.22511","article-title":"Psychotherapy versus pharmacotherapy for posttraumatic stress disorder: Systemic review and meta-analyses to determine first-line treatments","volume":"33","author":"Lee","year":"2016","journal-title":"Depression and Anxiety"},{"key":"10.1016\/j.pharmthera.2020.107551_bb5005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behavioural Brain Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0820","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0306-4530(97)00044-9","article-title":"Stress-restress: Effects on ACTH and fast feedback","volume":"22","author":"Liberzon","year":"1997","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb0825","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hup.348","article-title":"Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies","volume":"16","author":"Liechti","year":"2001","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0830","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/npp.2015.284","article-title":"Endocannabinoid modulation of predator stress-induced long-term anxiety in rats","volume":"41","author":"Lim","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0835","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.psychres.2017.08.052","article-title":"Increased circulating blood cell counts in combat-related PTSD: Associations with inflammation and PTSD severity","volume":"258","author":"Lindqvist","year":"2017","journal-title":"Psychiatry Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb0840","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/s41386-018-0064-2","article-title":"Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55, 212-2","volume":"43","author":"Lisboa","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0845","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00213-018-5127-x","article-title":"Tempering aversive\/traumatic memories with cannabinoids: A review of evidence from animal and human studies","volume":"236","author":"Lisboa","year":"2019","journal-title":"Psychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb0230","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1568026611109060609","article-title":"The role of corticotropin-releasing hormone in the pathophysiology of depression: Therapeutic implications","volume":"11","author":"Lloyd","year":"2011","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0850","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.copsyc.2016.12.001","article-title":"Cannabinoids as therapeutic for PTSD","volume":"14","author":"Loflin","year":"2017","journal-title":"Current Opinion in Psychology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0855","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1080\/00952990.2019.1604722","article-title":"A cross-sectional examination of choice and behavior of veterans with access to free medicinal cannabis","volume":"45","author":"Loflin","year":"2019","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0860","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbr.2015.02.009","article-title":"Sex differences in the stress response in SD rats","volume":"284","author":"Lu","year":"2015","journal-title":"Behavioural Brain Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb0865","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/0269881115592339","article-title":"No evidence for differential dose effects of hydrocortisone on intrusive memories in female patients with complex post-traumatic stress disorder\u2013a randomized, double-blind, placebo-controlled, crossover study","volume":"29","author":"Lud\u00e4scher","year":"2015","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0870","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bandc.2007.02.007","article-title":"The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition","volume":"65","author":"Lupien","year":"2007","journal-title":"Brain and Cognition"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0875","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0880","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2009.05013.x","article-title":"Clinical features associated with glucocorticoid receptor polymorphisms: An overview","volume":"1179","author":"Manenschijn","year":"2009","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0885","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","article-title":"Endocannabinoid system and psychiatry: In search of a neurobiological basis for detrimental and potential therapeutic effects","volume":"5","author":"Marco","year":"2011","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0890","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.psyneuen.2019.03.006","article-title":"High cortisol awakening response in the aftermath of workplace violence exposure moderates the association between acute stress disorder symptoms and PTSD symptoms","volume":"104","author":"Marin","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"6897","key":"10.1016\/j.pharmthera.2020.107551_bb0895","doi-asserted-by":"crossref","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0900","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pbb.2014.04.014","article-title":"Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC)","volume":"122","author":"Mayer","year":"2014","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0905","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1152\/physrev.00041.2006","article-title":"Physiologyandneurobiology of stress and adaptation: Central role of the brain","volume":"87","author":"McEwen","year":"2007","journal-title":"Physiological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0910","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.1997.tb48299.x","article-title":"The acute stress response following motor vehicle accidents and its relation to PTSD","volume":"821","author":"McFarlane","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0915","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.psyneuen.2010.10.007","article-title":"Cortisol response to acute trauma and risk of posttraumatic stress disorder","volume":"36","author":"McFarlane","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb0920","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/TA.0b013e318160ba1d","article-title":"The correlation between ketamine and posttraumatic stress disorder in burned service members","volume":"64","author":"McGhee","year":"2008","journal-title":"Journal of Trauma and Acute Care Surgery"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb0925","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1586\/ern.11.94","article-title":"Prolonged exposure therapy for post-traumatic stress disorder: A review of evidence and dissemination","volume":"11","author":"McLean","year":"2011","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb0930","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jpsychires.2011.03.006","article-title":"Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness","volume":"45","author":"McLean","year":"2011","journal-title":"Journal of Psychiatric Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb0935","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and \u03949-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"British Journal of Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb0940","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol\u2013recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chemistry & Biodiversity"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb0945","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.106.024877","article-title":"Cortisol and post-traumatic stress disorder in adults: Systematic review and meta-analysis","volume":"191","author":"Meewisse","year":"2007","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0950","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.lfs.2017.11.029","article-title":"Regulation of noradrenergic and serotonergic systems by cannabinoids: Relevance to cannabinoid-induced effects","volume":"192","author":"Mendiguren","year":"2018","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0955","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jpsychires.2017.02.002","article-title":"Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus","volume":"90","author":"Micale","year":"2017","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0960","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2016.146","article-title":"Inflammation in fear-and anxiety-based disorders: PTSD, GAD, and beyond","volume":"42","author":"Michopoulos","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb0965","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.drugpo.2015.01.009","article-title":"Trends in use of marijuana and attitudes toward marijuana among youth before and after decriminalization: The case of California 2007\u20132013","volume":"26","author":"Miech","year":"2015","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0970","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1196\/annals.1401.006","article-title":"The role of the orbitofrontal cortex in anxiety disorders","volume":"1121","author":"Milad","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb0975","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2009.06.026","article-title":"Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder","volume":"66","author":"Milad","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0980","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1196\/annals.1364.023","article-title":"Establishing an agenda for translational research on PTSD","volume":"1071","author":"Miller","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb0985","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1037\/0033-2909.133.1.25","article-title":"If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans","volume":"133","author":"Miller","year":"2007","journal-title":"Psychological Bulletin"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb0990","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/FBP.0000000000000253","article-title":"Cannabinoids and post-traumatic stress disorder: Clinical and preclinical evidence for treatment and prevention","volume":"27","author":"Mizrachi Zer-Aviv","year":"2016","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb0995","series-title":"Behavioral neurobiology of anxiety and its treatment. Current topics in Behavioral neurosciences","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/7854_2009_16","article-title":"Cannabinoids and anxiety","volume":"2","author":"Moreira","year":"2009"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1000","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2007.07.005","article-title":"Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors","volume":"54","author":"Moreira","year":"2008","journal-title":"Neuropharmacology"},{"issue":"51","key":"10.1016\/j.pharmthera.2020.107551_bb1005","doi-asserted-by":"crossref","first-page":"18333","DOI":"10.1073\/pnas.1420285111","article-title":"Endogenous cannabinoid release within prefrontal-limbic pathways affects memory consolidation of emotional training","volume":"111","author":"Morena","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb1015","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/npp.2017.305","article-title":"Enhancing endocannabinoid neurotransmission augments the efficacy of extinction training and ameliorates traumatic stress-induced behavioral alterations in rats","volume":"43","author":"Morena","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1020","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1523\/JNEUROSCI.2251-18.2018","article-title":"Upregulation of anandamide hydrolysis in the basolateral complex of amygdala reduces fear memory expression and indices of stress and anxiety","volume":"39","author":"Morena","year":"2019","journal-title":"Journal of Neuroscience"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cpr.2012.02.002","article-title":"Relations among posttraumatic stress disorder, comorbid major depression, and HPA function: A systematic review and meta-analysis","volume":"32","author":"Morris","year":"2012","journal-title":"Clinical Psychology Review"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107551_bb1030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.physbeh.2009.04.023","article-title":"Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: Role of gender and noradrenergic transmission","volume":"98","author":"Morrish","year":"2009","journal-title":"Physiology and Behavior"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1176\/appi.ps.201300056","article-title":"Changes in psychotherapy utilization among veterans with depression, anxiety, and PTSD","volume":"65","author":"Mott","year":"2014","journal-title":"Psychiatric Services"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1037\/tra0000355","article-title":"Sex differences in PTSD symptoms: A differential item functioning approach","volume":"11","author":"Murphy","year":"2018","journal-title":"Psychological Trauma Theory Research Practice and Policy"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1192\/bjp.180.4.363","article-title":"Dissociation and post-traumatic stress disorder: Two prospective studies of road traffic accident survivors","volume":"180","author":"Murray","year":"2002","journal-title":"The British Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yfrne.2013.12.003","article-title":"Glucocorticoid actions on synapses, circuits, and behavior: Implications for the energetics of stress","volume":"35","author":"Myers","year":"2014","journal-title":"Frontiers in Neuroendocrinology"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1055","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2017.01.005","article-title":"Constitutive increases in amygdalar corticotropin-releasing factor and fatty acid amide hydrolase drive an anxious phenotype","volume":"82","author":"Natividad","year":"2017","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/da.22031","article-title":"The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD","volume":"30","author":"Neumeister","year":"2013","journal-title":"Depression and Anxiety"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb1065","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/mp.2013.61","article-title":"Elevated brain cannabinoid CB 1 receptor availability in post-traumatic stress disorder: A positron emission tomography study","volume":"18","author":"Neumeister","year":"2013","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1070","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pnpbp.2019.03.017","article-title":"Cannabinoid interventions for PTSD: Where to next?","volume":"93","author":"Ney","year":"2019","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/15563650.2015.1004581","article-title":"Change in perceived risk associated with marijuana use in the United States from 2002 to 2012","volume":"53","author":"Okaneku","year":"2015","journal-title":"Clinical Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","article-title":"Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex","volume":"1127","author":"Oropeza","year":"2007","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.janxdis.2012.08.004","article-title":"The physical health consequences of PTSD and PTSD symptoms: A meta-analytic review","volume":"27","author":"Pacella","year":"2013","journal-title":"Journal of Anxiety Disorders"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.comppsych.2015.01.002","article-title":"The impact of posttraumatic symptoms and comorbid mental disorders on the health-related quality of life in treatment-seeking PTSD patients","volume":"58","author":"Pagotto","year":"2015","journal-title":"Comprehensive Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1095","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00213-006-0514-0","article-title":"The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats","volume":"188","author":"Pamplona","year":"2006","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.yfrne.2014.03.002","article-title":"Development of the HPA axis: Where and when do sex differences manifest?","volume":"35","author":"Panagiotakopoulos","year":"2014","journal-title":"Frontiers in Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13148-018-0569-x","article-title":"DNA methylation levels are associated with CRF 1 receptor antagonist treatment outcome in women with post-traumatic stress disorder","volume":"10","author":"Pape","year":"2018","journal-title":"Clinical Epigenetics"},{"issue":"7\u20138","key":"10.1016\/j.pharmthera.2020.107551_bb1110","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/dta.1377","article-title":"Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence","volume":"4","author":"Passie","year":"2012","journal-title":"Drug Testing and Analysis"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb1115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","article-title":"Inflammatory markers in post-traumatic stress disorder: A systematic review, meta-analysis, and meta-regression","volume":"2","author":"Passos","year":"2015","journal-title":"The Lancet Psychiatry"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb1120","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1125","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/sj.npp.1300535","article-title":"Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdala","volume":"30","author":"Patel","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pbb.2005.01.030","article-title":"Functional neuroanatomy of the endocannabinoid system","volume":"81","author":"Pazos","year":"2005","journal-title":"Pharmacology Biochemistry and Behavior"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-013-3020-1","article-title":"The CRF 1 receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: Comparison with paroxetine and d-cycloserine","volume":"228","author":"Philbert","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbr.2014.11.006","article-title":"The CRF1 receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: Comparison with paroxetine and d-cycloserine","volume":"279","author":"Philbert","year":"2015","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S0033291713000597","article-title":"Trajectories of PTSD risk and resilience in World Trade Center responders: An 8-year prospective cohort study","volume":"44","author":"Pietrzak","year":"2014","journal-title":"Psychological Medicine"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb1155","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nature Reviews Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1160","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.janxdis.2010.11.007","article-title":"Posttraumatic stress and marijuana use coping motives: The mediating role of distress tolerance","volume":"25","author":"Potter","year":"2011","journal-title":"Journal of Anxiety Disorders"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-3223(95)00088-7","article-title":"A behavioral animal model of posttraumatic stress disorder featuring repeated exposure to situational reminders","volume":"39","author":"Pynoos","year":"1996","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1170","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/sj.npp.1301555","article-title":"Neural mechanisms of extinction learning and retrieval","volume":"33","author":"Quirk","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1175","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2012.06.063","article-title":"Cannabinoid facilitation of fear extinction memory recall in humans","volume":"64","author":"Rabinak","year":"2013","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb1180","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/da.22243","article-title":"Focal and aberrant prefrontal engagement during emotion regulation in veterans with posttraumatic stress disorder","volume":"31","author":"Rabinak","year":"2014","journal-title":"Depression and Anxiety"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1185","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2007.06.012","article-title":"Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice","volume":"54","author":"Rademacher","year":"2008","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1190","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/13543784.2015.1020109","article-title":"Investigational drugs under development for the treatment of PTSD","volume":"24","author":"Ragen","year":"2015","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.nlm.2012.03.003","article-title":"Cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala prevent the stress-induced enhancement of a negative learning experience","volume":"97","author":"Ramot","year":"2012","journal-title":"Neurobiology of Learning and Memory"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2017.04.010","article-title":"Pre-treatment cortisol awakening response predicts symptom reduction in posttraumatic stress disorder after treatment","volume":"82","author":"Rapcencu","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb5000","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1038\/npp.2014.103","article-title":"The CB1 receptor antagonist AM251 impairs reconsolidation of pavlovian fear memory in the rat basolateral amygdala","volume":"39","author":"Ratano","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb5025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0269881113499207","article-title":"Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats","volume":"27","author":"Reich","year":"2013","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbr.2009.05.013","article-title":"Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats","volume":"203","author":"Reich","year":"2009","journal-title":"Behavioural Brain Research"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb1210","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1176\/ajp.152.11.1675","article-title":"Effect of previous trauma on acute plasma cortisol level following rape","volume":"152","author":"Resnick","year":"1995","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1471-4892(01)00117-5","article-title":"Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression","volume":"2","author":"Reul","year":"2002","journal-title":"Current Opinion in Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb1220","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41380-018-0272-5","article-title":"Animal models of PTSD: A challenge to be met","volume":"24","author":"Richter-Levin","year":"2019","journal-title":"Molecular Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb1225","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.psyneuen.2010.02.008","article-title":"Estrogenic regulation of limbic cannabinoid receptor binding","volume":"35","author":"Riebe","year":"2010","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1230","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yhbeh.2006.06.019","article-title":"Role of corticotropin releasing factor in anxiety disorders: A translational research perspective","volume":"50","author":"Risbrough","year":"2006","journal-title":"Hormones and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cpr.2015.02.007","article-title":"Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: A systematic review and meta-analysis","volume":"38","author":"Roberts","year":"2015","journal-title":"Clinical Psychology Review"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1240","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biopsych.2015.03.018","article-title":"Germ cell origins of posttraumatic stress disorder risk: The transgenerational impact of parental stress experience","volume":"78","author":"Rodgers","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1245","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopsych.2003.11.018","article-title":"Hypocortisolism and increased glucocorticoid sensitivity of pro-inflammatory cytokine production in Bosnian war refugees with posttraumatic stress disorder","volume":"55","author":"Rohleder","year":"2004","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1250","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neubiorev.2009.12.003","article-title":"Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder","volume":"35","author":"Rohleder","year":"2010","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb1255","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40261-014-0212-3","article-title":"Preliminary, open-label, pilot study of add-on oral \u0394 9-tetrahydrocannabinol in chronic post-traumatic stress disorder","volume":"34","author":"Roitman","year":"2014","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/bs.pmbts.2015.10.002","article-title":"Molecular mechanisms of cannabis signaling in the brain","volume":"137","author":"Ronan","year":"2016","journal-title":"Progress in Molecular Biology and Translational Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1265","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1196\/annals.1301.012","article-title":"Applying learning principles to the treatment of post-trauma reactions","volume":"1008","author":"Rothbaum","year":"2003","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb1270","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1038\/sj.npp.1301664","article-title":"Chronic \u0394 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: Behavioral and biochemical correlates","volume":"33","author":"Rubino","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1275","first-page":"1","article-title":"Individual variability in the recall of fear extinction is associated with phosphorylation of mitogen-activated protein kinase in the infralimbic cortex","author":"Russo","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb9000","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1101\/lm.039891.115","article-title":"The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation and extinction","volume":"22","author":"Sachser","year":"2015","journal-title":"Learning and Memory"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1280","doi-asserted-by":"crossref","first-page":"346","DOI":"10.31887\/DCNS.2011.13.2\/ksamuelson","article-title":"Post-traumatic stress disorder and declarative memory functioning: A review","volume":"13","author":"Samuelson","year":"2011","journal-title":"Dialogues in Clinical Neuroscience"},{"issue":"2, 3","key":"10.1016\/j.pharmthera.2020.107551_bb1285","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1155\/2011\/328054","article-title":"Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks","volume":"30","author":"Sarapas","year":"2011","journal-title":"Disease Markers"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1290","doi-asserted-by":"crossref","first-page":"107402","DOI":"10.1016\/j.pharmthera.2019.107402","article-title":"Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders","author":"Sartori","year":"2019","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1295","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0006-3223(03)00571-7","article-title":"CRF in PTSD with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects","volume":"54","author":"Sautter","year":"2003","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb1300","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euroneuro.2018.05.008","article-title":"Chronic exposure to cannabinoids before an emotional trauma may have negative effects on emotional function","volume":"28","author":"Sbarski","year":"2018","journal-title":"European Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107551_bb1305","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0006-3223(01)01270-7","article-title":"The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors","volume":"50","author":"Schelling","year":"2001","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb1310","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.biopsych.2003.09.014","article-title":"Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: A randomized study","volume":"55","author":"Schelling","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1315","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1516-4446(12)70057-0","article-title":"Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug","volume":"34","author":"Schier","year":"2012","journal-title":"Revista Brasileira de Psiquiatria"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1320","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-2005-918834","article-title":"Effects of ketamine medication on early and sustained PTSD symptoms","volume":"38","author":"Sch\u00f6nenberg","year":"2005","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1325","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/0269881107082481","article-title":"Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims","volume":"22","author":"Sch\u00f6nenberg","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb1330","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1111\/jcmm.13161","article-title":"Post-traumatic stress disorder and beyond: An overview of rodent stress models","volume":"21","author":"Sch\u00f6ner","year":"2017","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1335","first-page":"2","article-title":"Salivary cortisol and alpha-amylase as predictors of response to an internet-based treatment for German soldiers with PTSD","volume":"10","author":"Schumacher","year":"2019","journal-title":"European Journal of Psychotraumatology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1340","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/npp.2015.238","article-title":"Cannabinoids and glucocorticoids in the basolateral amygdala modulate hippocampal\u2013accumbens plasticity after stress","volume":"41","author":"Segev","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029988","article-title":"Stress hormones receptors in the amygdala mediate the effects of stress on the consolidation, but not the retrieval, of a non aversive spatial task","volume":"7","author":"Segev","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1350","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/npp.2013.292","article-title":"Cannabinoid receptor activation prevents the effects of chronic mild stress on emotional learning and LTP in a rat model of depression","volume":"39","author":"Segev","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1355","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1038\/s41386-018-0135-4","article-title":"Role of endocannabinoids in the hippocampus and amygdala in emotional memory and plasticity","volume":"43","author":"Segev","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb1360","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00005053-199208000-00005","article-title":"Posttraumatic stress disorder among injured survivors of a terrorist attack: Predictive value of early intrusion and avoidance symptoms","volume":"180","author":"Shalev","year":"1992","journal-title":"Journal of Nervous and Mental Disease"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1365","doi-asserted-by":"crossref","first-page":"542118","DOI":"10.3389\/fnbeh.2019.00091","article-title":"The divergent effects of CDPPB and cannabidiol on fear extinction and anxiety in a predator scent stress model of PTSD in rats","volume":"13","author":"Shallcross","year":"2019","journal-title":"Frontiers in Behavioral Neuroscience"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb1370","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1176\/appi.ps.201300234","article-title":"Associations of psychotherapy dose and SSRI or SNRI refills with mental health outcomes among veterans with PTSD","volume":"65","author":"Shin","year":"2014","journal-title":"Psychiatric Services"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1375","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.celrep.2014.11.001","article-title":"Genetic disruption of 2-arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation","volume":"9","author":"Shonesy","year":"2014","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1380","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nlm.2017.08.004","article-title":"The effects of cannabinoid receptors activation and glucocorticoid receptors deactivation in the amygdala and hippocampus on the consolidation of a traumatic event","volume":"144","author":"Shoshan","year":"2017","journal-title":"Neurobiology of Learning and Memory"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107551_bb1385","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/hipo.22755","article-title":"Cannabinoids prevent the differential long-term effects of exposure to severe stress on hippocampal-and amygdala-dependent memory and plasticity","volume":"27","author":"Shoshan","year":"2017","journal-title":"Hippocampus"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1390","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S2215-0366(14)00121-7","article-title":"Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: A systematic review and meta-analysis","volume":"2","author":"Sijbrandij","year":"2015","journal-title":"The Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171879","article-title":"The contribution of gender-based violence and network trauma to gender differences in post-traumatic stress disorder","volume":"12","author":"Silove","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1400","series-title":"Handbook of PTSD: Science and practice","first-page":"166","article-title":"Neurobiological alterations associated with PTSD","author":"Southwick","year":"2007"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1405","article-title":"HPA axis function and diurnal cortisol in post-traumatic stress disorder: A systematic review","volume":"100180","author":"Speer","year":"2019","journal-title":"Neurobiology of Stress"},{"issue":"9\u201310","key":"10.1016\/j.pharmthera.2020.107551_bb1410","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00213-017-4556-2","article-title":"Don\u2019t stress about CRF: Assessing the translational failures of CRF 1 antagonists","volume":"234","author":"Spierling","year":"2017","journal-title":"Psychopharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb1415","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.chiabu.2014.01.017","article-title":"Comorbidity of PTSD in anxiety and depressive disorders: Prevalence and shared risk factors","volume":"38","author":"Spinhoven","year":"2014","journal-title":"Child Abuse and Neglect"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1420","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuropharm.2011.06.012","article-title":"Pharmacological treatment of PTSD\u2013established and new approaches","volume":"62","author":"Steckler","year":"2012","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1425","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/da.22596","article-title":"Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review","volume":"34","author":"Steenkamp","year":"2017","journal-title":"Depression and Anxiety"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107551_bb1430","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0006-3223(96)00489-1","article-title":"Enhanced dexamethasone suppression of plasma cortisol in an adult women traumatized by childhood sexual abuse","volume":"42","author":"Stein","year":"1997","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1435","article-title":"Pharmacotherapy for post traumatic stress disorder (PTSD)","volume":"1","author":"Stein","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1440","doi-asserted-by":"crossref","first-page":"20803","DOI":"10.3402\/ejpt.v5.20803","article-title":"Gender and offender status predicting treatment success in refugees and asylum seekers with PTSD","volume":"5","author":"Stenmark","year":"2014","journal-title":"European Journal of Psychotraumatology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1445","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.psyneuen.2015.12.021","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis response to acute psychosocial stress: Effects of biological sex and circulating sex hormones","volume":"66","author":"Stephens","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb5010","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment.","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb1450","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.euroneuro.2015.02.001","article-title":"\u03949-tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption","volume":"25","author":"Stern","year":"2015","journal-title":"European Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb1455","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.biopsych.2013.03.011","article-title":"Hair cortisol as a biomarker of traumatization in healthy individuals and posttraumatic stress disorder patients","volume":"74","author":"Steudte","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1460","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3758\/s13415-014-0299-2","article-title":"Trauma exposure is associated with increased context-dependent adjustments of cognitive control in patients with posttraumatic stress disorder and healthy controls","volume":"14","author":"Steudte-Schmiedgen","year":"2014","journal-title":"Cognitive, Affective, & Behavioral Neuroscience"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1465","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/hipo.20537","article-title":"Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB1 and CB2 cannabinoid receptors of neonatal rats","volume":"19","author":"Su\u00e1rez","year":"2009","journal-title":"Hippocampus"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1470","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/104012371002200406","article-title":"Effects of exogenous glucocorticoid on combat-related PTSD symptoms","volume":"22","author":"Suris","year":"2010","journal-title":"Annals of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1475","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz199","article-title":"Predicting stress resilience and vulnerability: Brain-derived neurotrophic factor and rapid eye movement sleep as potential biomarkers of individual stress responses","volume":"43","author":"Sweeten","year":"2019","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1480","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/HRP.0000000000000188","article-title":"Glucocorticoids and hippocampal structure and function in PTSD","volume":"26","author":"Szeszko","year":"2018","journal-title":"Harvard Review of Psychiatry"},{"issue":"32","key":"10.1016\/j.pharmthera.2020.107551_bb1485","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1523\/JNEUROSCI.1067-15.2015","article-title":"Sex differences in molecular signaling at inhibitory synapses in the hippocampus","volume":"35","author":"Tabatadze","year":"2015","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1490","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/jnp.2009.21.2.iv","article-title":"Endocannabinoids: Stress, anxiety, and fear","volume":"21","author":"Taber","year":"2009","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1495","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.irn.2015.09.003","article-title":"Endocannabinoid regulation of neuroendocrine systems","volume":"125","author":"Tasker","year":"2015","journal-title":"In International Review of Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1500","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pnpbp.2018.11.013","article-title":"Modelling posttraumatic stress disorders in animals","volume":"90","author":"T\u00f6r\u00f6k","year":"2019","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1505","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3999(02)00429-4","article-title":"Hypothalamic\u2013pituitary\u2013adrenal axis, neuroendocrine factors and stress","volume":"53","author":"Tsigos","year":"2002","journal-title":"Journal of Psychosomatic Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1510","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.56","article-title":"Association of trauma exposure with proinflammatory activity: A transdiagnostic meta-analysis","volume":"4","author":"Tursich","year":"2014","journal-title":"Translational Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1515","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/sj.npp.1301224","article-title":"Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task","volume":"32","author":"Varvel","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1520","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jc.2002-020354","article-title":"Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: A potential marker for glucocorticoid sensitivity, potency, and bioavailability","volume":"88","author":"Vermeer","year":"2003","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1525","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.comppsych.2010.10.001","article-title":"The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program","volume":"52","author":"Villagonzalo","year":"2011","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1530","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jts.21798","article-title":"Salivary cortisol lower in posttraumatic stress disorder","volume":"26","author":"Wahbeh","year":"2013","journal-title":"Journal of Traumatic Stress"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107551_bb1535","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0378-1119(02)00598-X","article-title":"Transcriptional regulation of the mouse fatty acid amide hydrolase gene","volume":"291","author":"Waleh","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1540","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cpr.2016.10.002","article-title":"Medical cannabis and mental health: A guided systematic review","volume":"51","author":"Walsh","year":"2017","journal-title":"Clinical Psychology Review"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1545","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","article-title":"Cannabinoids and neuroinflammation","volume":"141","author":"Walter","year":"2004","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1550","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biopsych.2014.05.026","article-title":"Linking hair cortisol levels to phenotypic heterogeneity of posttraumatic stress symptoms in highly traumatized Chinese women","volume":"77","author":"Wang","year":"2015","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1555","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jad.2017.08.066","article-title":"Interaction between early-life stress and FKBP5 gene variants in major depressive disorder and post-traumatic stress disorder: A systematic review and meta-analysis","volume":"225","author":"Wang","year":"2018","journal-title":"Journal of Affective Disorders"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1560","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.psyneuen.2005.06.010","article-title":"Altered cortisol awakening response in posttraumatic stress disorder","volume":"31","author":"Wessa","year":"2006","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107551_bb1565","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.4088\/JCP.14m09475","article-title":"Marijuana use is associated with worse outcomes in symptom severity and violent behavior in patients with PTSD","volume":"76","author":"Wilkinson","year":"2015","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2020.107551_bb1570","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.psychres.2014.09.005","article-title":"Pharmacological blockade of memory reconsolidation in posttraumatic stress disorder: Three negative psychophysiological studies","volume":"225","author":"Wood","year":"2015","journal-title":"Psychiatry Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1575","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neulet.2011.05.013","article-title":"Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse","volume":"502","author":"Xing","year":"2011","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1580","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fneur.2014.00161","article-title":"Differential expression of brain cannabinoid receptors between repeatedly stressed males and females may play a role in age and gender-related difference in traumatic brain injury: Implications from animal studies","volume":"5","author":"Xing","year":"2014","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1585","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1749-6632.1997.tb48269.x","article-title":"Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder a","volume":"821","author":"Yehuda","year":"1997","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107551_bb1590","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0193-953X(02)00002-3","article-title":"Current status of cortisol findings in post-traumatic stress disorder","volume":"25","author":"Yehuda","year":"2002","journal-title":"Psychiatric Clinics of North America"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107551_bb1595","first-page":"29","article-title":"Risk and resilience in posttraumatic stress disorder","volume":"65","author":"Yehuda","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107551_bb1600","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/00005053-199006000-00004","article-title":"Low urinary cortisol excretion in patients with posttraumatic stress disorder","volume":"178","author":"Yehuda","year":"1990","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1620","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1176\/ajp.152.7.982","article-title":"Low urinary cortisol excretion in holocaust survivors with posttraumatic stress disorder","volume":"152","author":"Yehuda","year":"1995","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1605","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/ajp.148.4.499","article-title":"Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder","volume":"148","author":"Yehuda","year":"1991","journal-title":"The American Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1615","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archpsyc.1995.03950190065010","article-title":"Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder","volume":"52","author":"Yehuda","year":"1995","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107551_bb1610","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0006-3223(93)90252-9","article-title":"Relationship between lymphocyte glucocorticoid receptor number and urinary-free cortisol excretion in mood, anxiety, and psychotic disorder","volume":"34","author":"Yehuda","year":"1993","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107551_bb1625","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0306-4530(03)00052-0","article-title":"Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder","volume":"29","author":"Yehuda","year":"2004","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1630","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biopsych.2014.02.006","article-title":"Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder","volume":"77","author":"Yehuda","year":"2015","journal-title":"Biological Psychiatry"},{"issue":"17","key":"10.1016\/j.pharmthera.2020.107551_bb1635","first-page":"23","article-title":"Posttraumatic stress disorder in the general population and in children","volume":"62","author":"Yule","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107551_bb1640","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2217\/pgs.14.40","article-title":"Towards a personalized treatment in depression: Endocannabinoids, inflammation and stress response","volume":"15","author":"Zajkowska","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107551_bb1645","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/hipo.22577","article-title":"Sex differences in hippocampal response to endocannabinoids after exposure to severe stress","volume":"26","author":"Zer-Aviv","year":"2016","journal-title":"Hippocampus"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107551_bb1650","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.euroneuro.2011.06.001","article-title":"High dose hydrocortisone immediately after trauma may alter the trajectory of PTSD: Interplay between clinical and animal studies","volume":"21","author":"Zohar","year":"2011","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107551_bb1655","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.euroneuro.2017.01.011","article-title":"The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal\u2013amygdala\u2013insular circuit","volume":"27","author":"Zubedat","year":"2017","journal-title":"European Neuropsychopharmacology"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820300796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:04:21Z","timestamp":1759010661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820300796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":339,"alternative-id":["S0163725820300796"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107551","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids as therapeutics for PTSD","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107551"}}